International Journal of Clinical Oncology

, Volume 22, Issue 4, pp 715–725 | Cite as

Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection

  • Tsuyoshi Notake
  • Akira Kobayashi
  • Hiroji Shinkawa
  • Takuya Kawahara
  • Akira Shimizu
  • Takahide Yokoyama
  • Kiyoshi Hasegawa
  • Norihiro Kokudo
  • Yutaka Matsuyama
  • Masatoshi Makuuchi
  • Shin-ichi Miyagawa
Original Article

Abstract

Background

The aim of this study was to construct and validate a nomogram for predicting survival after the intrahepatic recurrence of hepatocellular carcinoma (HCC) following an initial hepatectomy.

Methods

A primary cohort of 268 patients who underwent curative hepatectomy for HCC at Shinshu University Hospital between 1990 and 2010 was retrospectively studied. A nomogram was constructed based on independent prognostic factors for overall survival after recurrence. The predictive performance was evaluated using the concordance index (c-index) and a calibration curve. The nomogram was then externally validated in a cohort of patients from Tokyo University Hospital (n = 296).

Results

In multivariate analysis, the following 5 variables were identified as independent predictors of overall survival and incorporated into the nomogram—Japan Integrated Stage score at initial liver resection, platelet count at initial liver resection, time until intrahepatic recurrence, vascular invasion at recurrence, and type of treatment used for intrahepatic recurrence. The nomogram had a c-index of 0.75 (95% confidence interval 0.60–0.85) for the Shinshu cohort and 0.71 (0.57–0.81) for the Tokyo cohort. The predicted 3- and 5-year survival probabilities corresponded well with the actual outcomes.

Conclusions

The established nomogram might be useful for estimating survival after the intrahepatic recurrence of HCC.

Keywords

Hepatocellular carcinoma Nomogram External validation 

Supplementary material

10147_2017_1114_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 17 kb)

References

  1. 1.
    El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576CrossRefPubMedGoogle Scholar
  2. 2.
    Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–386CrossRefPubMedGoogle Scholar
  3. 3.
    Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255CrossRefPubMedGoogle Scholar
  4. 4.
    Belghiti J, Panis Y, Farges O et al (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Okada S, Shimada K, Yamamoto J et al (1994) Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106:1618–1624CrossRefPubMedGoogle Scholar
  6. 6.
    Adachi E, Maeda T, Matsumata T et al (1995) Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108:768–775CrossRefPubMedGoogle Scholar
  7. 7.
    Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338CrossRefPubMedGoogle Scholar
  8. 8.
    Poon RT, Fan ST, Lo CM et al (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229:216–222CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Majno PE, Sarasin FP, Mentha G et al (2000) Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 31:899–906CrossRefPubMedGoogle Scholar
  10. 10.
    Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Kakazu T, Makuuchi M, Kawasaki S et al (1993) Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 40:337–341PubMedGoogle Scholar
  12. 12.
    Hu RH, Lee PH, Yu SC et al (1996) Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 120:23–29CrossRefPubMedGoogle Scholar
  13. 13.
    Nagasue N, Kohno H, Hayashi T et al (1996) Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 83:127–131CrossRefPubMedGoogle Scholar
  14. 14.
    Shimada M, Takenaka K, Taguchi K et al (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227:80–85CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Minagawa M, Makuuchi M, Takayama T et al (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703–710CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Itamoto T, Nakahara H, Amano H et al (2007) Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141:589–597CrossRefPubMedGoogle Scholar
  17. 17.
    Kubo S, Takemura S, Uenishi T et al (2008) Second hepatic resection for recurrent hepatocellular carcinoma in patients with chronic hepatitis C. World J Surg 32:632–638CrossRefPubMedGoogle Scholar
  18. 18.
    Wu CC, Cheng SB, Yeh DC et al (2009) Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. Br J Surg 96:1049–1057CrossRefPubMedGoogle Scholar
  19. 19.
    Roayaie S, Bassi D, Tarchi P et al (2011) Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol 55:346–350CrossRefPubMedGoogle Scholar
  20. 20.
    Kobayashi A, Kawasaki S, Miyagawa S et al (2006) Results of 404 hepatic resections including 80 repeat hepatectomies for hepatocellular carcinoma. Hepatogastroenterology 53:736–741PubMedGoogle Scholar
  21. 21.
    Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 14:2319–2329CrossRefPubMedGoogle Scholar
  22. 22.
    Okuwaki Y, Nakazawa T, Kokubu S et al (2009) Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma. Am J Gastroenterol 104:2747–2753CrossRefPubMedGoogle Scholar
  23. 23.
    Okazaki M, Yamasaki S, Ono H et al (1993) Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology 40:320–323PubMedGoogle Scholar
  24. 24.
    Lee PH, Lin WJ, Tsang YM et al (1995) Clinical management of recurrent hepatocellular carcinoma. Ann Surg 222:670–676CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Shim JH, Kim KM, Lee YJ et al (2010) Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection. Ann Surg Oncol 17:869–877CrossRefPubMedGoogle Scholar
  26. 26.
    Shimada M, Takenaka K, Gion T et al (1996) Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 111:720–726CrossRefPubMedGoogle Scholar
  27. 27.
    Chen WT, Chau GY, Lui WY et al (2004) Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 30:414–420CrossRefPubMedGoogle Scholar
  28. 28.
    Taura K, Ikai I, Hatano E et al (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 244:265–273CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Shah SA, Cleary SP, Wei AC et al (2007) Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 141:330–339CrossRefPubMedGoogle Scholar
  30. 30.
    Shimada K, Sakamoto Y, Esaki M et al (2007) Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 14:2337–2347CrossRefPubMedGoogle Scholar
  31. 31.
    Choi GH, Kim DH, Kang CM et al (2008) Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol 15:618–629CrossRefPubMedGoogle Scholar
  32. 32.
    Kawano Y, Sasaki A, Kai S et al (2009) Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol 35:174–179CrossRefPubMedGoogle Scholar
  33. 33.
    Kishi Y, Saiura A, Yamamoto J et al (2011) Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg 396:1093–1100CrossRefPubMedGoogle Scholar
  34. 34.
    Kattan MW, Potters L, Blasko JC et al (2001) Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 58:393–399CrossRefPubMedGoogle Scholar
  35. 35.
    Bochner BH, Kattan MW, Vora KC (2006) Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 24:3967–3972CrossRefPubMedGoogle Scholar
  36. 36.
    Ferrone CR, Kattan MW, Tomlinson JS et al (2005) Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol 23:7529–7535CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Han DS, Suh YS, Kong SH et al (2012) Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol 30:3834–3840CrossRefPubMedGoogle Scholar
  38. 38.
    Rudloff U, Jacks LM, Goldberg JI et al (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762–3769CrossRefPubMedGoogle Scholar
  39. 39.
    Kattan MW, Gonen M, Jarnagin WR et al (2008) A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:282–287CrossRefPubMedGoogle Scholar
  40. 40.
    Cho CS, Gonen M, Shia J et al (2008) A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg 206:281–291CrossRefPubMedGoogle Scholar
  41. 41.
    Shim JH, Jun MJ, Han S et al (2015) Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg 261:939–946CrossRefPubMedGoogle Scholar
  42. 42.
    Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304CrossRefPubMedGoogle Scholar
  43. 43.
    Miyagawa S, Makuuchi M, Kawasaki S et al (1995) Criteria for safe hepatic resection. Am J Surg 169:589–594CrossRefPubMedGoogle Scholar
  44. 44.
    Liebman HA, Furie BC, Tong MJ et al (1984) Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310:1427–1431CrossRefPubMedGoogle Scholar
  45. 45.
    Lok AS, Sterling RK, Everhart JE et al (2010) Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 138:493–502CrossRefPubMedGoogle Scholar
  46. 46.
    Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23:2109–2123CrossRefPubMedGoogle Scholar
  47. 47.
    Kudo M, Chung H, Haji S et al (2004) Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 40:1396–1405CrossRefPubMedGoogle Scholar
  48. 48.
    Balachandran VP, Gonen M, Smith JJ et al (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:e173–180CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    The Liver Cancer Study Group of Japan (2010) The general rules for clinical and pathological study of primary liver cancer, 3rd edn. Kanehara & Co., Ltd, TokyoGoogle Scholar
  50. 50.
    Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649CrossRefPubMedGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2017

Authors and Affiliations

  • Tsuyoshi Notake
    • 1
  • Akira Kobayashi
    • 1
  • Hiroji Shinkawa
    • 2
  • Takuya Kawahara
    • 3
  • Akira Shimizu
    • 1
  • Takahide Yokoyama
    • 1
  • Kiyoshi Hasegawa
    • 2
  • Norihiro Kokudo
    • 2
  • Yutaka Matsuyama
    • 3
  • Masatoshi Makuuchi
    • 4
  • Shin-ichi Miyagawa
    • 1
  1. 1.Department of SurgeryShinshu University School of MedicineMatsumotoJapan
  2. 2.Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of MedicineUniversity of TokyoTokyoJapan
  3. 3.Department of Biostatistics, School of Public HealthUniversity of TokyoTokyoJapan
  4. 4.Hepato-Biliary-Pancreatic Surgery Division, Department of SurgeryJapanese Red Cross Medical CenterTokyoJapan

Personalised recommendations